<DOC>
	<DOCNO>NCT02041273</DOCNO>
	<brief_summary>A relative bioavailability study commercial palbociclib free base hard capsule isethionate salt palbociclib capsule ( use Phase 1 2 study ) different fast condition .</brief_summary>
	<brief_title>Relative Bioavailability Of Palbociclib ( PD-0332991 ) Under Fed And Fasted Conditions</brief_title>
	<detailed_description />
	<mesh_term>Palbociclib</mesh_term>
	<criteria>Healthy male subject and/or female subject nonchildbearing potential age 18 55 year . Evidence personally sign date informed consent document indicate subject inform pertinent aspect study . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease . Any condition possibly affect drug absorption .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>bioavailability</keyword>
	<keyword>bioequivalence</keyword>
	<keyword>AUC</keyword>
	<keyword>Cmax</keyword>
</DOC>